世界中医药
文章摘要
引用本文:徐敏1,程迎迎1,李鹏飞1,蒙飞1,胡堇叶2,吴倩2,赵苏瑛1.黄芪皂苷对不同类型乳腺癌细胞的作用效应及机制研究[J].世界中医药,2023,(06):.  
黄芪皂苷对不同类型乳腺癌细胞的作用效应及机制研究
Effects and Mechanisms of Astragaloside in the Treatment of Different Breast Cancer Cell Lines
投稿时间:2021-06-16  
DOI:10.3969/j.issn.1673-7202.2023.06.008
中文关键词:  黄芪皂苷  中药  乳腺癌  机制  效应  抑制  凋亡  抗肿瘤
English Keywords:Astragaloside  Chinese medicine  Breast cancer  Mechanism  Effect  Inhibition  Apoptosis  Anti-tumor
基金项目:江苏省中医药局科技项目(LZ13052);江苏省中医院“益中”项目(2019Y48)
作者单位
徐敏1,程迎迎1,李鹏飞1,蒙飞1,胡堇叶2,吴倩2,赵苏瑛1 1 南京中医药大学附属医院南京210029 2 南京医科大学公共卫生学院南京211166 
摘要点击次数: 540
全文下载次数: 0
中文摘要:
      目的:研究中药黄芪皂苷对不同类型乳腺癌细胞的作用效应及对胞内miRNA-155表达的影响,探讨其发挥效应可能的途径,为阐明中药的抗肿瘤作用机制和其临床应用的推广提供理论依据。方法:选择代表不同类型的乳腺癌细胞系MCF-7,MDA-MB-231和T-47D,选取对数生长期的细胞随机分为对照组和加药组,在加药组中加入不同浓度的黄芪皂苷溶液(终浓度0 μg/mL、12.5 μg/mL、25 μg/mL、50 μg/mL、100 μg/mL),绘制细胞生长曲线并检测细胞克隆形成情况,并用流式细胞仪检测细胞凋亡,使用qRT-PCR测定FOX3a、SOCS1的mRNA表达水平。结果:黄芪皂苷在体外能抑制3种乳腺癌细胞系的生长和增殖,并且诱导乳腺癌细胞凋亡,但作用效应不尽相同。对T-47D的作用最强并且呈剂量依赖型,对MDA-MB-231和MCF-7的作用稍弱并呈时间-剂量依赖型。黄芪皂苷能使MCF-7和T-47D中的FOX3a、SOCS1表达降低,而MDA-MB-231中FOX3a,SOCS1升高。结论:黄芪皂苷对乳腺癌有抑制增殖、诱导凋亡的作用,并且对不同的细胞类型作用效应不同。在MCF-7和T-47D中,黄芪皂苷通过活化JAK-STAT-SOCS和INS/IGF-1信号通路中的分子FOX3a,SOCS1来发挥效应,而在MDA-MB-231中则不然,其作用的准确途径和机制尚需进一步地深入研究。
English Summary:
      To study the effects of astragaloside on different breast cancer cell lines and the expression of miRNA-155,explore the possible pathways,and thus provide a theoretical basis for elucidating the mechanism and promoting the application of Chinese medicines in the treatment of cancers.Methods:MCF-7,MDA-MB-231,and T-47D cells in the logarithmic growth phase were randomly assigned into a control group and an observation group.Astragaloside solutions were added to reach different final concentrations(0,12.5,25,50,and 100 μg/mL) in the observation group.Cell growth curves were established and colony formation was examined.The cell apoptosis was detected by flow cytometry,and the mRNA levels of FOX3a and SOCS1 were determined by qRT-PCR.Results:Astragaloside inhibited the growth and proliferation and induced the apoptosis of the three breast cancer cell lines in vitro,demonstrating the strongest effect on T-47D cells in a dose-dependent manner and weaker effects on MDA-MB-231 and MCF-7 cells in a time-and dose-dependent manner.Astragaloside down-regulated the expression levels of FOX3a and SOCS1 in MCF-7 and T-47D cells,while it up-regulated the expression levels of FOX3a and SOCS1 in MDA-MB-231 cells.Conclusion:Astragaloside inhibited the proliferation and induced the apoptosis of breast cancer cells,with varied effects on different cell lines.Astragaloside can activate the expression of FOX3a and SOCS1 via JAK-STAT-SOCS and INS/IGF-1 signaling pathways in MCF-7 and T-47D cells,but not in MDA-MB-231 cells.The specific mechanism remains to be studied.
查看全文  查看/发表评论  下载PDF阅读器